Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treat-To-Target Trial of Continuous Subcutaneous, Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation (SAPT-NODAT)

NCT01680185 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT01680185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01680185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treat-To-Target Trial of Continuous Subcutaneous, Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation (SAPT-NODAT)
Lead sponsor
Medical University of Vienna
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2012
Completion date
May 31, 2018
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperglycemia